Programmed death ligand-1 and MET co-expression is a poor prognostic factor in gastric cancers after resection.

about

A gene expression-based risk model reveals prognosis of gastric cancer.The prognostic value of programmed cell death ligand 1 expression in non-Hodgkin lymphoma: a meta-analysis

P2860

Q49202365-0D5312A8-7E18-4C57-B030-7668023D5C36 Q58804963-3B82E51B-CD9E-4336-9038-DFA06A0FEC65

P2860

Programmed death ligand-1 and MET co-expression is a poor prognostic factor in gastric cancers after resection.

Item

http://www.wikidata.org/entity/Q47143363

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Programmed death ligand-1 and ...... stric cancers after resection.

@en

Programmed death ligand-1 and ...... stric cancers after resection.

@nl

type

Item

label

Programmed death ligand-1 and ...... stric cancers after resection.

@en

Programmed death ligand-1 and ...... stric cancers after resection.

@nl

prefLabel

Programmed death ligand-1 and ...... stric cancers after resection.

@en

Programmed death ligand-1 and ...... stric cancers after resection.

@nl

P1476

Programmed death ligand-1 and ...... stric cancers after resection.

@en

P2093

Eun Sook Nam

http://www.w3.org/2001/XMLSchema#string

Ho Suk Kang

http://www.w3.org/2001/XMLSchema#string

Hye Kyung Lee

http://www.w3.org/2001/XMLSchema#string

Hye-Rim Park

http://www.w3.org/2001/XMLSchema#string

Ji-Young Choe

http://www.w3.org/2001/XMLSchema#string

Jinwon Seo

http://www.w3.org/2001/XMLSchema#string

Kab-Choong Kim

http://www.w3.org/2001/XMLSchema#string

Kyueng-Whan Min

http://www.w3.org/2001/XMLSchema#string

Mi Jung Kwon

http://www.w3.org/2001/XMLSchema#string

Seong Jin Cho

http://www.w3.org/2001/XMLSchema#string

P2860

Clinicopathologic Significance and Prognostic Value of B7 Homolog 1 in Gastric Cancer: A Systematic Review and Meta-Analysis

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.

PD-L1 is an independent prognostic predictor in gastric cancer of Western patients.

The Next Immune-Checkpoint Inhibitors: PD-1/PD-L1 Blockade in Melanoma

Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients

Helicobacter pylori and Molecular Markers as Prognostic Indicators for Gastric Cancer in Korea

Randomized phase II trial of Onartuzumab in combination with erlotinib in patients with advanced non-small-cell lung cancer.

Novel roles of c-Met in the survival of renal cancer cells through the regulation of HO-1 and PD-L1 expression.

Inducible expression of B7-H1 (PD-L1) and its selective role in tumor site immune modulation.

Programmed cell death ligand 1 (PD-L1) expression on gastric cancer and its relationship with clinicopathologic factors.

P304

82399-82414

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.19390

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-07-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29137273

http://www.w3.org/2001/XMLSchema#string

P932

5669899

http://www.w3.org/2001/XMLSchema#string

Programmed death ligand-1 and MET co-expression is a poor prognostic factor in gastric cancers after resection.

about

P2860

P2860

Programmed death ligand-1 and MET co-expression is a poor prognostic factor in gastric cancers after resection.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932